CSE filing·Sep 30, 2025
Change of AuditorHealthcare & Pharma
Nawaloka Hospitals Plc
NHL.N0000Healthcare · Hospital/Nursing Management
Rs 13.00
+1.56%as of Aug 3, 2026
Price history
+100.00%
P/E
14.0
P/B
2.94
EPS
Rs 0.93
Div Yield
0.00%
Market Cap
Rs 18.3B
Beta
2.46
ROE
1.2%
Op Margin
16.6% (-6.4pp)
Annual fundamentals
| Year | Revenue | Net profit | EPS |
|---|---|---|---|
| 2025 | Rs 11.0B | Rs 56.4M | 0.04 |
| 2024 | Rs 10.4B | Rs -304.7M | -0.22 |
| 2023 | Rs 9.3B | Rs -2.4B | -1.73 |
| 2022 | Rs 15.3B | Rs -96.6M | -0.07 |
| 2021 | Rs 11.8B | Rs 501.3M | 0.36 |
| 2020 | Rs 8.6B | Rs 16.0M | 0.01 |
| 2019 | Rs 8.8B | Rs -565.1M | -0.40 |
Recent dividends
- 2017Rs 0.10
- 2016Rs 0.08
- 2015Rs 0.07
- 2014Rs 0.06
- 2012Rs 0.05
About Nawaloka Hospitals Plc
Nawaloka Hospitals PLC is a private healthcare provider in Sri Lanka delivering inpatient and outpatient clinical services, diagnostic and laboratory testing, and allied healthcare services. The Group operates purpose-built hospital facilities and specialist multidisciplinary centres of excellence in areas such as cardiology, oncology, orthopaedics and neurology, and maintains accredited diagnostic laboratories. The company expanded its service portfolio to include telemedicine and digital health solutions (including the "NawalokaCare" mobile app and electronic medical records), a surgical hub, and dedicated international patient services delivered through the ELITE Medical Centre and the International Patient Care Centre (IPCC). Its international patient offering includes end-to-end medical tourism packages with logistical support, multilingual assistance and culturally aligned amenities for overseas patients. Nawaloka emphasises quality and accreditation (ISO 9001:2015 and SLAB ISO 15189:2012 for its laboratories), sustainability initiatives and partnerships such as its role as Official Healthcare Partner of Sri Lanka Cricket. The Group serves both domestic and international patients, attracting referrals from markets including the Maldives, the Middle East, Europe and Australia.
AI analysis
No AI research report for Nawaloka Hospitals Plc yet. Generate one from everything we track: prices, valuation, news sentiment, financials and corporate actions.
Generate an analysis →News sentiment
Describes news flow, not a forecastLast 30 days
Not enough news to read
1 article in 30 days: 1 positive, 0 negative, 0 neutral.
24 months positive negative 3-month net
Recent news
EconomyNext·Sep 10, 2025·Market commentaryPositive
Sri Lanka stocks close up, C T Holdings, Cargills push turnoverColombo Stock Exchange rose as the ASPI gained 0.46% to 20,769, with a C T Holdings crossing contributing Rs 3.6bn to turnover; C T Holdings closed down Rs 29.75 at Rs 689. Banks led gains with HNB, NDB and DFCC up, while Sampath and Nations Trust fell.
Healthcare & PharmaConsumer Staples (FMCG)
CSE filing·Sep 10, 2025
Clarification on Newspaper article published in “Daily Mirror” on 09th September 2025Healthcare & Pharma
Daily FT·Jul 5, 2025·Management or board change
Iconic banker Rienzie Wijetilleke passes awayRienzie T. Wijetilleke, a veteran banker, has died aged 85; he served 24 years at Hatton National Bank (including as Managing Director and Non-Executive Chairman) and also held leadership/director roles at Sunshine Holdings, Nawaloka Hospitals and DFCC Bank.
Healthcare & Pharma
Ada Derana·Mar 18, 2025·Capacity or capexPositive
Nawaloka Hospitals Introduces South Asia’s First AI-Powered MRI Scanner, Advancing Diagnostic Excellence in Sri LankaNawaloka Hospitals PLC commissioned South Asia’s first AI-driven Canon Vantage Orian MRI on March 18, 2025, completing a USD 4.5 million radiology upgrade. The AI-powered scanner improves image clarity and speed, can avoid contrast injections, and is intended to raise diagnostic standards at the hospital.
Healthcare & PharmaIT & Digital
CSE filing·Jan 27, 2025
Appointment of Senior Independent DirectorHealthcare & Pharma
CSE filing·Jan 20, 2025
Reconstitution of Board CommitteesHealthcare & Pharma
CSE filing·Jan 6, 2025
Unusual Trading Activity in the Securities of Nawaloka Hospitals PLC (NHL.N0000)Healthcare & Pharma
Daily FT·Nov 21, 2024·Management or board change
Dr. Chamara Bandara appointed to Nawaloka Hospitals BoardNawaloka Hospitals Plc (NHL.N0000) appointed Dr. Chamara Bandara as an Independent Non-Executive Director. Dr. Bandara holds a PhD in Business Management, an MBA, has founded multiple firms and currently serves as an independent director of Kapruka Holdings PLC (KPHL.N0000).
Healthcare & Pharma
Daily FT·Oct 21, 2024·Management or board change
Virann de Zoysa appointed to Nawaloka Hospitals BoardNawaloka Hospitals PLC has appointed Virann de Zoysa as an Independent Non-Executive Director. De Zoysa holds an undergraduate degree in Finance and Accounting and an MBA, and is a director at Associated Motorways with experience in finance, project management and hospitality.
Healthcare & Pharma
Healthcare sector: what is happening
Last 30 days to Aug 4, 2026SLPMA dominated sector news, urging a long-term government buyback to back local pharma manufacturing, quicker raw-material import approvals and stable incentives, plus a national push to make pharmaceuticals an export engine through a task force and faster regulation. Cross-border activity featured a 31-member Indian delegation on 8-10 July for B2B sessions including pharma. Colombo Port City moved to seek operators for an international hospital. Cybersecurity risks to hospitals gained attention.
The stories behind it
Auto-generated from 8 sector news articles over 30 days. Not investment advice. 2 more stories on the sentiment page.